Investigational Drug Information for danicamtiv
✉ Email this page to a colleague
What is the development status for investigational drug danicamtiv?
danicamtiv is an investigational drug.
There have been 5 clinical trials for danicamtiv.
The most recent clinical trial was a Phase 1 trial, which was initiated on August 19th 2020.
The most common disease conditions in clinical trials are Heart Failure, Cardiomyopathy, Dilated, and Cardiomyopathies. The leading clinical trial sponsors are Bristol-Myers Squibb, MyoKardia, Inc., and [disabled in preview].
Summary for danicamtiv
| US Patents | 0 |
| International Patents | 24 |
| US Patent Applications | 15 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2020-08-19) |
| Vendors | 25 |
Recent Clinical Trials for danicamtiv
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants | Bristol-Myers Squibb | Phase 1 |
| A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart Failure | Bristol-Myers Squibb | Phase 1 |
| A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants | Bristol-Myers Squibb | Phase 1 |
Clinical Trial Summary for danicamtiv
Top disease conditions for danicamtiv
Top clinical trial sponsors for danicamtiv
US Patents for danicamtiv
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for danicamtiv
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| danicamtiv | Australia | AU2016209200 | 2035-01-22 | ⤷ Subscribe |
| danicamtiv | Brazil | BR112017015627 | 2035-01-22 | ⤷ Subscribe |
| danicamtiv | Canada | CA2974370 | 2035-01-22 | ⤷ Subscribe |
| danicamtiv | Chile | CL2017001871 | 2035-01-22 | ⤷ Subscribe |
| danicamtiv | China | CN107428719 | 2035-01-22 | ⤷ Subscribe |
| danicamtiv | Costa Rica | CR20170370 | 2035-01-22 | ⤷ Subscribe |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
